GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and ...

Fintel reports that on March 13, 2025, Guggenheim initiated coverage of GH Research (NasdaqGM:GHRS) with a Buy recommendation. Analyst Price Forecast Suggests 187.58% Upside As of March 4 ...

Shares of GH Research PLC (NASDAQ:GHRS – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports.

It takes 40 gallons of tree sap to create one gallon of maple syrup. The formula might come from science, but the result is pure magic, especially to Vermonters, who’ve been tapping and sugaring ...

GH Research PLC (NASDAQ:GHRS – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $10.55, but opened at $10.99. GH Research shares last traded at $ ...